About TransOMIC
TransOMIC was a Healthcare company based in Huntsville (United States) founded in 2012 by Gwen Fewell, Rusla Du Breuil, and Blake Simmons. Provider of omics reagents for research and development. It operates on a B2B model. TransOMIC has raised $1.14 million across 2 funding rounds. Its chief executive, as recorded, is Blake Simmons. The company is recorded as dissolved. Its focus areas include Biotechnology, Reagents and Supplies and Omics Products. Its legal entity is Transomic Technologies, Inc. Its competitors include GenScript and Rejuvenate Bio; 2 of its 2 listed competitors have raised funding.
Company details
TransOMIC provider of omics reagents for research and development through providing healthcare solutions, advancing biotech innovations, reagents and supplies, and omics products. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Huntsville, United States
- Founders Gwen Fewell, Rusla Du Breuil, Blake Simmons
- SectorsHealthcare
- Website transomic.com
- Legal Name Transomic Technologies, Inc
- Total Equity Funding$1.14M (USD)
in 2 rounds
- Latest Funding Round$1.12M (USD), Seed
Apr 2015
Funding Insights of TransOMIC
TransOMIC has successfully raised a total of $1.14M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.12 million completed in April 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.14M
- Total Rounds 2
- Last Round Seed — $1.12M
- First Round $20,000
(Mar 2012)
All 2 funding rounds of TransOMIC with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2015 | $1.12M | Seed | – | – | – |
| Mar 2012 | $20,000 | Seed | – | – | – |
People of TransOMIC
8 people are tracked at TransOMIC (6 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Gwen Fewell | Chief Commercial Officer and Co-Founder | Leadership |
Rusla Du Breuil | Co-Founder, CTO | Leadership |
Blake Simmons | Co-Founder and CEO | Leadership |
Christy O. | Director of Scientific Technical Support and Customer Service | Leadership |
Jason Fewell | Chief Scientific Officer | Leadership |
Hao Feng | Laboratory Director | Leadership |
Taylor Dunn | Product Development Scientist | Team |
Abby Horton | Laboratory Technician | Team |
Complete people profiles for TransOMIC
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of TransOMIC
3 dated milestones of TransOMIC across 3 years, from founding to its latest funding, stage changes and deals.
- Founded TransOMIC is founded.
- Funding First funding round of $20K.
- Funding Latest funding round, Seed, of $1.1M.
Competitors of TransOMIC
TransOMIC has 2 listed competitors in our database, 2 of them funded. They include GenScript and Rejuvenate Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. |
Detailed competitors of TransOMIC
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of TransOMIC
Websites that share an audience with TransOMIC (transomic.com).
Websites whose visitors overlap most with TransOMIC. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| vigenebio.com | 77% | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as TransOMIC (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Transomic
Complete news archive for TransOMIC
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TransOMIC
TransOMIC was founded in 2012.
TransOMIC is headquartered in Huntsville, United States. It is registered at Huntsville, Alabama, United States.
Blake Simmons is the CEO of TransOMIC, as recorded in our data. They have also founded this company.
TransOMIC is a funded company, having raised a total of $1.14M across 2 funding rounds to date. The company's 1st funding round was a Seed of $20K, raised on Mar 2012.
TransOMIC provider of omics reagents for research and development through providing healthcare solutions, advancing biotech innovations, reagents and supplies, and omics products. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
TransOMIC's top competitors include GenScript and Rejuvenate Bio.
TransOMIC operates through Transomic Technologies, Inc.